Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques

Velstra, B.; Vonk, M.A.; Bonsing, B.A.; Mertens, B.J.; Nicolardi, S.; Huijbers, A.; ... ; Tollenaar, R.A.E.M. (2015)

Article / Letter to editor

• Screening
• MALDI-TOF
• Biomarker signature
• Proteomics
• Clinical decision making

• All authors: Velstra, B.; Vonk, M.A.; Bonsing, B.A.; Mertens, B.J.; Nicolardi, S.; Huijbers, A.; Vasen, H.; Deelder, A.M.; Mesker, W.E.; Burgt, Y.E.M. van der; Tollenaar, R.A.E.M.
• Date: 2015-03-31
• Journal: Journal of Cancer Research and Clinical Oncology
• Volume: 141
• Issue: 3
• Pages: 531 - 541
• DOI: doi:10.1007/s00432-014-1812-2